Recombinant multi-species IL-12/IL-23 p40/IL12B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-12/IL-23 p40/IL12B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a subunit of interleukin 12, a cytokine that acts on T and natural killer cells, and has a broad array of biological activities. Interleukin 12 is a disulfide-linked heterodimer composed of the 40 kD cytokine receptor like subunit encoded by this gene, and a 35 kD subunit encoded by IL12A. This cytokine is expressed by activated macrophages that serve as an essential inducer of Th1 cells development. This cytokine has been found to be important for sustaining a sufficient number of memory/effector Th1 cells to mediate long-term protection to an intracellular pathogen. Overexpression of this gene was observed in the central nervous system of patients with multiple sclerosis (MS), suggesting a role of this cytokine in the pathogenesis of the disease. The promoter polymorphism of this gene has been reported to be associated with the severity of atopic and non-atopic asthma in children. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CLMF,CLMF2,Cytotoxic lymphocyte maturation factor 40 kDa subunit (CLMF p40),IL-12,IL-12 subunit p40,IL-12.p40,IL-12B,IL-23 p40,IL12B,IL12p40,IMD28,IMD29,Il-12b,Il-12p40,Il12,Il12b,Il12p40,Interleukin-12 subunit beta,NK cell stimulatory factor chain 2 (NKSF2),NKSF,NKSF2,p40
Go
to IL-12/IL-23 p40/IL12B products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T95385-Ag-1/ GM-Tg-hg-T95385-Ag-2 | Human IL-12/IL-23 p40/IL12B protein | Human |
| GM-Tg-rg-T95385-Ag-1/ GM-Tg-rg-T95385-Ag-2 | Rat IL-12/IL-23 p40/IL12B protein | Rat |
| GM-Tg-mg-T95385-Ag-1/ GM-Tg-mg-T95385-Ag-2 | Mouse IL-12/IL-23 p40/IL12B protein | Mouse |
| GM-Tg-cynog-T95385-Ag-1/ GM-Tg-cynog-T95385-Ag-2 | Cynomolgus/Rhesus macaque IL-12/IL-23 p40/IL12B protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T95385-Ag-1/ GM-Tg-felg-T95385-Ag-2 | Feline IL-12/IL-23 p40/IL12B protein | Feline |
| GM-Tg-cang-T95385-Ag-1/ GM-Tg-cang-T95385-Ag-2 | Canine IL-12/IL-23 p40/IL12B protein | Canine |
| GM-Tg-bovg-T95385-Ag-1/ GM-Tg-bovg-T95385-Ag-2 | Bovine IL-12/IL-23 p40/IL12B protein | Bovine |
| GM-Tg-equg-T95385-Ag-1/ GM-Tg-equg-T95385-Ag-2 | Equine IL-12/IL-23 p40/IL12B protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T95385-Ag-1/ GM-Tg-hg-T95385-Ag-2;
GM-Tg-rg-T95385-Ag-1/ GM-Tg-rg-T95385-Ag-2;
GM-Tg-mg-T95385-Ag-1/ GM-Tg-mg-T95385-Ag-2; GM-Tg-cynog-T95385-Ag-1/ GM-Tg-cynog-T95385-Ag-2; GM-Tg-felg-T95385-Ag-1/ GM-Tg-felg-T95385-Ag-2; GM-Tg-cang-T95385-Ag-1/ GM-Tg-cang-T95385-Ag-2; GM-Tg-bovg-T95385-Ag-1/ GM-Tg-bovg-T95385-Ag-2; GM-Tg-equg-T95385-Ag-1/ GM-Tg-equg-T95385-Ag-2 |
| Products Name | IL-12/IL-23 p40/IL12B protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | IL-12/IL-23 p40/IL12B |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-12/IL-23 p40/IL12B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.